Ausgabe 4/2018
Inhalt (26 Artikel)
Fracture liaison services for osteoporosis in the Asia-Pacific region: current unmet needs and systematic literature review
Y. -F. Chang, C. -F. Huang, J. -S. Hwang, J. -F. Kuo, K. -M. Lin, H. -C. Huang, S. Bagga, A. Kumar, F. -P. Chen, C. -H. Wu
Appropriateness criteria for treatment of osteoporotic vertebral compression fractures
S. Luthman, J. Widén, F. Borgström
Systematic review and meta-analysis of prevalence of sarcopenia in post acute inpatient rehabilitation
I. Churilov, L. Churilov, R. J. MacIsaac, E. I. Ekinci
A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates
P. van den Berg, P. M. M. van Haard, E. van der Veer, P. P. Geusens, J. P. van den Bergh, D. H. Schweitzer
Feasibility of opportunistic osteoporosis screening in routine contrast-enhanced multi detector computed tomography (MDCT) using texture analysis
M. R. K. Mookiah, A. Rohrmeier, M. Dieckmeyer, K. Mei, F. K. Kopp, P. B. Noel, J. S. Kirschke, T. Baum, K. Subburaj
Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland
I. Nurmi-Lüthje, R. Tiihonen, E.-L. Paattiniemi, H. Naboulsi, S. Pigg, H. Sarkkinen, J.-P. Kaukonen, A. Toivanen, K. Salmio, M. Kataja, P. Lüthje
Correction to: Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland
I. Nurmi-Lüthje, R. Tiihonen, E.-L. Paattiniemi, H. Naboulsi, S. Pigg, H. Sarkkinen, J.-P. Kaukonen, A. Toivanen, K. Salmio, M. Kataja, P. Lüthje
Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study
I. Tamimi, B. Nicolau, H. Eimar, S. Arekunnath Madathil, A. Kezouh, I. Karp, F. Tamimi
The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study
N. C. Wright, E. R. Hooker, C. M. Nielson, K. E. Ensrud, S. L. Harrison, E. S. Orwoll, E. Barrett-Connor
Bone density and microarchitecture in hepatitis C and HIV-coinfected postmenopausal minority women
M. T. Yin, A. RoyChoudhury, K. Nishiyama, T. Lang, J. Shah, S. Olender, D. C. Ferris, C. Zeana, A. Sharma, B. Zingman, M. Bucovsky, I. Colon, E. Shane
Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial
C.-L. Shen, S. Yang, M. D. Tomison, A. W. Romero, C. K. Felton, H. Mo
Is the timed loaded standing test a valid measure of back muscle endurance in people with vertebral osteoporosis?
M. Newman, R. Newman, T. Hughes, K. Vadher, K. L. Barker
Urinary Pentosidine levels negatively associates with trabecular bone scores in patients with type 2 diabetes mellitus
Y. J. Choi, S. Y. Ock, Y. Jin, J. S. Lee, S. H. Kim, Y. -S. Chung
Diversity of activity participation determines bone mineral content in the lower limbs of pre-pubertal children with developmental coordination disorder
S. S. M. Fong, D. Vackova, A. W. M. Choi, Y. T. Y. Cheng, T. T. T. Yam, X. Guo
Lower risk of hip fractures among Swedish women with large hips?
S. Klingberg, K. Mehlig, V. Sundh, B. L. Heitmann, L. Lissner
Bisphosphonate use after clinical fracture and risk of new fracture
J. Bergman, A. Nordström, P. Nordström
FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis
R. C. Hamdy, E. Seier, K. Whalen, W. A. Clark, K. Hicks, T. B. Piggee
Implementing a fracture liaison service open model of care utilizing a cloud-based tool
S. L. Greenspan, A. Singer, K. Vujevich, B. Marchand, D. A. Thompson, Y.-J. Hsu, D. Vaidya, L. S. Stern, D. Zeldow, D. B. Lee, S. Karp, R. Recker
Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures
S. Roux, I. Gaboury, N. Gionet-Landry, M.-P. Garant, M.-C. Beaulieu, N. Carrier, F. Cabana, G. Boire
Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals
V. C. Kok, J.-T. Horng, M. N. Wang, Z.-Y. Chen, J.-T. Kuo, G.-D. Hung
Teriparatide therapy for severe, refractory osteoradionecrosis of the jaw
Y. H. Cha, N. Hong, Y. Rhee, I.-H. Cha
Tumor-induced osteomalacia in association with PTEN-negative Cowden syndrome
J. A. Berglund, R. I. Gafni, F. Wodajo, E. W. Cowen, D. El-Maouche, R. Chang, C. C. Chen, L. C. Guthrie, A. A. Molinolo, M. T. Collins
Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib
N. Binkley, D. Krueger, A. E. de Papp